MustGrow Biologics Closes Financing At Final Figure Of $7.1 Million

MustGrow Biologics (CSE: MGRO) this morning closed off its previously announced private placement financing. The company managed to raise significant funds under the raise, bringing in total gross proceeds of $7.1 million.

Originally pegged at $2.0 million, the financing was subsequently tripled in size due to strong investor demand, especially among certain high net worth individuals. It appears that there was still excess demand as well, with the upsized $6.9 financing finally closing out at $7.1 million.

A total of 2.7 million units of the company were sold under the offering at a price of $2.60 per unit. Each unit contains one common share and one half of a purchase warrant, with each warrant exercisable at $4.00 for a period of two years from the date of issuance.

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

Proceeds from the offering are to be used for the development of the firms tech pipeline, as well as for working capital and general corporate purposes.

As previously identified Ira Gluskin and related parties to Gluskin subscribed for $1.0 million under the financing.

MustGrow Biologics last traded at $3.35 on the CSE.


FULL DISCLOSURE: MustGrow Biologics Corp is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover MustGrow Biologics Corp on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Epic Gold Outlines 150,700 Indicated Ounces at 2.26 G/T in Updated Benoist Resource

Related News

MustGrow Biologics Enters Exclusive Arrangement With Bayer

MustGrow Biologics (CSE: MGRO) has entered arrangements with another big name in the life sciences...

Friday, January 21, 2022, 08:34:22 AM

MustGrow Announces 100% Control of Clubroot Disease With TerraMG

MustGrow Biologics Corp (CSE: MGRO) this morning announced test results for use of its patented...

Wednesday, May 27, 2020, 08:43:22 AM

MustGrow Biologics Isolates Third Molecule From Mustard Plant

MustGrow Biologics (CSE: MGRO) continues to conduct research on the mustard plant and extract different...

Wednesday, March 3, 2021, 08:46:13 AM

MustGrow Biologics Updates Market On Its Biopesticide Product Pipeline

MustGrow Biologics (CSE: MGRO) this morning provided an update to the market on the status...

Wednesday, December 9, 2020, 07:22:59 AM

MustGrow Enters Exclusive Marketing And Distribution Agreement With NexusBioAg

MustGrow Biologics (CSE: MGRO) has seen further validation of its tech this morning, with the...

Wednesday, July 20, 2022, 08:23:29 AM